Skip to main content
Caplight Logo









Avatrial

Avatrial

Private
CambridgeHealthcare & Life Scienceshttps://avatrial.life/

Last Round

Grant

Nov 29, 2024

Total Funding Raised

$95,000

Company Overview

Avatrial is a biotechnology company that offers integrated, end-to-end services for cancer drug discovery, using human tissue, multi-omic data generation, and machine learning for biomarker identification.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Revenue Share

AI Layer

Application

Keywords

cancer drug discoverydrug discovery platformAI for drug discoveryAI biotechmulti-omicsbiomarker discoverytarget identificationprecision oncologytarget validationpatient-derived modelsorganoidsdrug discovery services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Avatrial Comparables

Compare Avatrial with similar companies based on industry and business-model similarity.

Avatrial comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Signet Therapeutics
76%
CELLphenomics GmbH
76%
Insitro
74%

Avatrial Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 29, 2024
AcceleratorJul 2, 2024

Key People

Founding team and executive leadership

Kourosh Saeb-Parsy

Founder & CEO

Founding Team

Avatrial Investors

Notable investors and investment history

Avatrial investors
InvestorRounds
National Quantum Computing CentreGrant

Avatrial Filings

Explore SEC and related filing metadata, where available.

Avatrial filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Avatrial's valuation, stock price, and market status.

Is Avatrial a public or private company?

Avatrial is a private company.

What is the current stock price of Avatrial?

Avatrial is a private company with no public stock price. No recent secondary market data is available.

How much is Avatrial worth (valuation)?

Valuation information for Avatrial is not publicly available.

Can I buy Avatrial stock?

Avatrial shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Avatrial's last funding round?

Avatrial's most recent funding round was Grant on November 29, 2024.

Who are the main investors in Avatrial?

Key investors in Avatrial include National Quantum Computing Centre.

Will Avatrial IPO soon?

No public IPO plans have been announced for Avatrial.

How can I track Avatrial secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Avatrial's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge
Year Founded2019
Last FundingNov 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?